Noteworthy HGSI-MEDI move quickly on vaccines

Human Genome Sciences Inc. entered into its third platform technology collaboration with another biotech company, this one a collaboration to create antibacterial vaccines and immunotherapeutics with MedImmune Inc.

The announcement came the same week as a report in Science detailing the success of HGSI's affiliate, The Institute for Genomic Research, in sequencing the Haemophilus influenzae genome using a novel method (see Other research news page B9). HGSI has rights to the work done at TIGR.